TY - JOUR
T1 - PML surfs into HIPPO tumor suppressor pathway
AU - Strano, Sabrina
AU - Fausti, Francesca
AU - Agostino, Silvia Di
AU - Sudol, Marius
AU - Blandino, Giovanni
PY - 2013
Y1 - 2013
N2 - Growth arrest, inhibition of cell proliferation, apoptosis, senescence, and differentiation are the most characterized effects of a given tumor suppressor response. It is becoming increasingly clear that tumor suppression results from the integrated and synergistic activities of different pathways. This implies that tumor suppression includes linear, as well as lateral, crosstalk signaling. The latter may happen through the concomitant involvement of common nodal proteins. Here, we discuss the role of Promyelocytic leukemia protein (PML) in functional cross-talks with the HIPPO and the p53 family tumor suppressor pathways. PML, in addition to its own anti-tumor activity, contributes to the assembly of an integrated and superior network that may be necessary for the maximization of the tumor suppressor response to diverse oncogenic insults.
AB - Growth arrest, inhibition of cell proliferation, apoptosis, senescence, and differentiation are the most characterized effects of a given tumor suppressor response. It is becoming increasingly clear that tumor suppression results from the integrated and synergistic activities of different pathways. This implies that tumor suppression includes linear, as well as lateral, crosstalk signaling. The latter may happen through the concomitant involvement of common nodal proteins. Here, we discuss the role of Promyelocytic leukemia protein (PML) in functional cross-talks with the HIPPO and the p53 family tumor suppressor pathways. PML, in addition to its own anti-tumor activity, contributes to the assembly of an integrated and superior network that may be necessary for the maximization of the tumor suppressor response to diverse oncogenic insults.
KW - Interaction
KW - Pathway
KW - Signaling
KW - Transcription
KW - Tumor suppression
UR - http://www.scopus.com/inward/record.url?scp=84885434303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885434303&partnerID=8YFLogxK
U2 - 10.3389/fonc.2013.00036
DO - 10.3389/fonc.2013.00036
M3 - Article
AN - SCOPUS:84885434303
SN - 2234-943X
VL - 3 MAR
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - Article 00036
ER -